RedRock Pharmacy
“RedRock Pharmacy 1240 E 100 S #220, St. George, UT 84790 801-433-9500 redrockhomepharmacy.com”
Source: medgm.org · Verified 2026-09-01
MEDGm Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: month-to-month compounded semaglutide at $179 with the partner pharmacies named
7.5
★★★★☆3.8/5
MEDGm's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
$179/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at MEDGm →
No insurance needed · Vetted by our editors
MEDGm is a Delaware-registered telehealth platform selling compounded semaglutide and tirzepatide, with the clinical side run by OpenLoop Health providers. Month-to-month pricing is $179 for the semaglutide injection, $249 for an oral dissolving tablet and $279 for tirzepatide, each including the consultation, medication and shipping. Neither the drug name nor the plan ladder appears until you submit your name, email and phone. Brand Wegovy, Zepbound and Ozempic are advertised separately on a membership-plus-drug-cost basis.
By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $179/moPrice shown up frontIncludes medication + consultPharmacy namedNo FDA letter on record
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
MEDGm at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo ($179 is the month-to-month rate, struck through from $299 at MEDGm's own checkout. The prepay tiers are not all cheap...)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How MEDGm scores
Six columns, each one computed from something MEDGm has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
5.4/10$179/month is 5% below the register median of $189 for compounded semaglutide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
8.0/10names its dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
7.0/10The price covers medication, consult, shipping.
6weighted dimensions
588sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on MEDGm
Last checked September 2026- Re-read the price on file across 6 dose or plan tiers
- Checked state coverage: all 50
- Established what the monthly figure covers, and what it leaves out
- Confirmed which compounding pharmacy fills the order, and its accreditation
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with MEDGm involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1MEDGm publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3A prescription is dispensed by RedRock Pharmacy, which MEDGm names publicly. Most sellers in this register do not.
- 4The monthly price is recorded as covering medication, consult, shipping.
Price shown before you start
- Cheapest standing monthly prices on record: semaglutide $179, tirzepatide $279. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether MEDGm serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
MEDGm support, as documented
- Phone
- +1 (214) 667-2145
- support@medgm.org
Cancelling MEDGm
Read from what MEDGm publishes in its own terms. Where a line says the seller does not publish something, that is the finding — we looked and it is not stated. Terms change; check the seller’s current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly, or a 3, 6 or 12-month bundle billed in full upfront; cancellation must be requested at least 72 hours before the next billing date
- Refund policy
- The Subscription Service fee is non-refundable, except for the exceptions specifically identified in the Refund Policy below.
- Early-termination fee
- None
GLP-1 medications MEDGm offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Weekly injection, month to monthCompounded
$179/mo
semaglutide
$179 is the month-to-month rate, struck through from $299 at MEDGm's own checkout. The prepay tiers are not all cheaper: 3 months costs $249/mo and 6 months $219/mo, both more than paying monthly. Only the 12-month tier undercuts it, at $169/mo billed as a single $2,028 charge.
Oral ODT (dissolving tablet), month to monthCompounded
$249/mo
semaglutide
$249/mo for the oral dissolving tablet, sold as a $70 upgrade on the semaglutide injection and struck through from $369. Prepay tiers run $319/mo for 3 months, $289/mo for 6, and $239/mo for 12 billed as a single $2,868 charge.
Weekly injection, month to monthCompounded
$279/mo
tirzepatide
$279/mo, struck through from $399, and not advertised at any price on the public pages. Prepay tiers run $349/mo for 3 months, $319/mo for 6 billed as $1,914, and $269/mo for 12 billed as $3,228 - the 3 and 6-month tiers again cost more than paying monthly.
Required membership (brand Zepbound billed separately)Brand-name
$99/mo
tirzepatide
The $99 buys the membership only. MEDGm does not publish what the Zepbound itself costs and lists availability as subject to change. Its signup flow sells compounded medication only.
Required membership (brand Wegovy billed separately)Brand-name
$99/mo
semaglutide
The $99 buys the membership only. MEDGm does not publish what the Wegovy itself costs and lists availability as subject to change. Wegovy is not offered in its signup flow.
Required membership (brand Ozempic billed separately)Brand-name
$171/mo
semaglutide
The $171 buys the membership only. MEDGm does not publish what the Ozempic itself costs and lists availability as subject to change. Ozempic is not offered in its signup flow.
Check the price yourself before you pay
Every figure here was read off MEDGm's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
MEDGm compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that MEDGm routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
Health Warehouse
“Health Warehouse 7107 Industrial Rd, Florence, KY 41042 800-748-7001 healthwarehouse.com”
Source: medgm.org · Verified 2026-09-01
Precision Medicine
“Precision Medicine 2657 Merrick Road, Bellmore, NY 11710 516-833-6262 precisionmeds.com”
Source: medgm.org · Verified 2026-09-01
Triad Rx
“Triad Rx 26258 Pollard Road, Daphne, AL 36526 251-380-7630 triadrx.us”
Source: medgm.org · Verified 2026-09-01
In its favor
- Semaglutide at $179 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- The monthly figure covers medication, consult, shipping
- Names 4 dispensing pharmacies, which most sellers in this register do not do
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MEDGm charges
MEDGm charges $179/month.
- Compounded semaglutide — $179/month
- Compounded semaglutide — $249/month
- Compounded tirzepatide — $279/month
- Brand-name tirzepatide — $99/month
- Brand-name semaglutide — $99/month
- Brand-name semaglutide — $171/month
The median across the GLP-1 providers we track is about $170/month, so this lands mid-market — close enough that the deciding factor is unlikely to be price.
DudeMeds dispenses semaglutide and tirzepatide from $175/month, which makes it the honest comparison to run before committing here.
What MEDGm dispenses
MEDGm prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. Both routes are available: the FDA-approved pen, or a compounded version at lower cost. The distinction is not cosmetic — the approved product has been reviewed for safety, efficacy and manufacturing quality, and a compounded preparation has not.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at MEDGm at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
On the record: it treats patients in all 50 states and it names the pharmacy that fills its prescriptions. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded, the named pharmacy is the detail that matters most here — it is the license you can actually look up. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- injections are the thing keeping you from starting
- you need access regardless of where you live
Our read
MEDGm lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits. Bodybuilding Health+ is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
MEDGm's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Score: 7.5/10Best for: month-to-month compounded semaglutide at $179 with the partner pharmacies namedFrom: $179/mo
Before you pay MEDGm
Starting at $179 a month. Check today's price, then book the free consultation.
Where MEDGm is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider RxSpan MD.
Alternatives to MEDGm
7.5/ 10
Verified partnerSynergy Rx
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
★★★★☆3.8/5
Editorial score · methodology
199/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full Synergy Rx review →6.8/ 10
Verified partnerRxSpan MD
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
★★★☆☆3.4/5
Editorial score · methodology
179/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+LegitScript Verified
Get StartedRead full RxSpan MD review →6.7/ 10
Verified partnerLuvo Health
Best for: moving between compounded and brand without changing seller
★★★☆☆3.4/5
Editorial score · methodology
249/mo
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Luvo Health review →Frequently Asked Questions
MEDGm is a Delaware-registered telehealth platform selling compounded semaglutide and tirzepatide, with the clinical side run by OpenLoop Health providers. Month-to-month pricing is $179 for the semaglutide injection, $249 for an oral dissolving tablet and $279 for tirzepatide, each including the consultation, medication and shipping. Neither the drug name nor the plan ladder appears until you submit your name, email and phone. Brand Wegovy, Zepbound and Ozempic are advertised separately on a membership-plus-drug-cost basis. Our six-dimension score for it is 7.5/10.
MEDGm is a real, operating US company. We checked its posted prices and what it sells against its own site, and the register scores it 7.5/10 on six dimensions. A score is a finding about the seller. It is not advice about you.
MEDGm starts at $179 a month. The pricing table above carries every tier we have on record.
MEDGm publishes no promo or coupon code. Its $179 a month is the cash price, and there is nothing to apply a code against. Sites advertising "MEDGm discount codes" are not a source we verify. Any live offer applies without a code.
MEDGm says it treats patients in all 50 states.
MEDGm sells semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro). Both are listed in FDA-approved brand form and in a cheaper compounded form. A needle-free oral form is listed as well.
MEDGm lists both. Compounded semaglutide and tirzepatide come out of a licensed compounding pharmacy and cost less. The brand pens are the FDA-approved reference products and cost more. What you give up on each path is set out in the review above.
MEDGm is cash only. No insurance enters the transaction, which also means no plan is going to absorb any of the cost for you.
MEDGm says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what we could confirm and what the seller leaves unstated.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. MEDGm runs that whole sequence on its own site.
No FDA action sits against MEDGm in our record. What we flag instead is mostly disclosure: No state list is on record here, so whether it serves your state cannot be confirmed from this page; Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of those is a safety finding. All of them are things worth pricing in before you buy.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MEDGm review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MEDGm's current pricing
Plans start at $179 a month. The free consultation is where you learn whether you qualify, and what it costs today.
From $179/mo
MEDGm